- Home
- GOSS vs KINS Comparison
GOSS vs KINS Comparison
Compare GOSS & KINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- KINS
- Stock Information
- Founded
- GOSS 2015
- KINS 1886
- Country
- GOSS United States
- KINS United States
- Employees
- GOSS N/A
- KINS N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- KINS Property-Casualty Insurers
- Sector
- GOSS Health Care
- KINS Finance
- Exchange
- GOSS Nasdaq
- KINS Nasdaq
- Market Cap
- GOSS 203.3M
- KINS 197.1M
- IPO Year
- GOSS 2019
- KINS N/A
- Fundamental
- Price
- GOSS $1.11
- KINS $21.67
- Analyst Decision
- GOSS Strong Buy
- KINS Strong Buy
- Analyst Count
- GOSS 4
- KINS 1
- Target Price
- GOSS $7.50
- KINS $6.50
- AVG Volume (30 Days)
- GOSS 1.5M
- KINS 381.5K
- Earning Date
- GOSS 05-20-2025
- KINS 05-08-2025
- Dividend Yield
- GOSS N/A
- KINS N/A
- EPS Growth
- GOSS N/A
- KINS 5417.04
- EPS
- GOSS N/A
- KINS 1.60
- Revenue
- GOSS $114,701,000.00
- KINS $169,875,701.00
- Revenue This Year
- GOSS N/A
- KINS $40.63
- Revenue Next Year
- GOSS $172.31
- KINS $6.92
- P/E Ratio
- GOSS N/A
- KINS $13.35
- Revenue Growth
- GOSS N/A
- KINS 18.52
- 52 Week Low
- GOSS $0.50
- KINS $4.01
- 52 Week High
- GOSS $1.55
- KINS $20.16
- Technical
- Relative Strength Index (RSI)
- GOSS 55.81
- KINS 67.78
- Support Level
- GOSS $1.06
- KINS $16.60
- Resistance Level
- GOSS $1.26
- KINS $18.88
- Average True Range (ATR)
- GOSS 0.11
- KINS 1.38
- MACD
- GOSS 0.03
- KINS 0.20
- Stochastic Oscillator
- GOSS 67.95
- KINS 91.06
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About KINS Kingstone Companies Inc.
Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals.